“Pulmonary” disease refers to many disorders affecting the lungs, including asthma, chronic obstructive pulmonary disease, infections such as influenza, pneumonia and tuberculosis, lung cancer and many other breathing problems, including sleep apnea, pulmonary fibrosis and sarcoidosis.
Source: Centers for Disease Control and Prevention, Health Statistics for US Adults, National Center for health Statistics, National Heart, Lung & Blood Institute
At NYU Winthrop Hospital, laboratory scientists and pulmonary, pediatric and cardiovascular specialists are pursuing a better understanding of heart and lung diseases through studies of cell development and function, as well as tissue injury, recovery and the role of heredity in the overall process. The goal is to prevent lung and heart damage in children and adults in order to improve survival and outcome. Research by NYU Winthrop physicians has led to understanding of how a popular antioxidant, superoxide dismutase, significantly affects treatment and outcome for premature babies with fragile, undeveloped lungs. Additionally, clinical investigations into the next generation of therapies for asthma, allergies, COPD, emphysema and lung cancer are ongoing, with a focus on bringing the most current treatments to patients.